Credit Suisse Maintains Ascendis Pharma A (ASND) Neutral Recommendation
29/4 13:39
Fintel reports that on April 28, 2023, Credit Suisse maintained coverage of Ascendis Pharma A (NASDAQ:ASND) with a Neutral recommendation....
|
|
|
29/4 13:39
Fintel reports that on April 28, 2023, Credit Suisse maintained coverage of Ascendis Pharma A (NASDAQ:ASND) with a Neutral recommendation....